Evidence map›Paper›PMID 40908800›Full record

ArticleAdvanced healthcare materials2026

Xeno-Free Biocompatible Peptide-Based Bioinks Reinforced with Cellulose Nanofibers for 3D Printing.

Francesca Netti, Mor Tsuriano, Noam Rattner, Vania Altobelli, Yoav Dan, Lihi Adler-Abramovich

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Role of cellulose and its derivatives for 3D printing of bone tissue scaffolds.Frontiers in bioengineering and biotechnology · 2026
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Francesca NettiDepartment of Oral Biology, The Goldschleger School of Dental Medicine, Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, 26745, ISRAEL.ORCID 0000-0002-2152-3340
Mor TsurianoDepartment of Oral Biology, The Goldschleger School of Dental Medicine, Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, 26745, ISRAEL.
Noam RattnerDepartment of Oral Biology, The Goldschleger School of Dental Medicine, Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, 26745, ISRAEL.
Vania AltobelliDepartment of Oral Biology, The Goldschleger School of Dental Medicine, Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, 26745, ISRAEL.
Yoav DanDepartment of Oral Biology, The Goldschleger School of Dental Medicine, Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, 26745, ISRAEL.
Lihi Adler-AbramovichDepartment of Oral Biology, The Goldschleger School of Dental Medicine, Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, 26745, ISRAEL.ORCID 0000-0003-3433-0625

Funding

H2020 European Research Council 948102Israel Science Foundation 2422/24Ministry of Science, Technology & Space, Israel
6 · The paper itself

Abstract

Tissue regeneration is a complex biological process with limited self-repair capacity, necessitating engineered solutions to restore both mechanical integrity and biological functionality. In tissue engineering and regenerative medicine, 3D printing has emerged as a promising tool for fabricating scaffolds that mimic the natural extracellular matrix (ECM). However, many bioinks are derived from animal sources, posing risks of pathogen contamination and immune responses. Additionally, many bioinks require chemical cross-linking to achieve mechanical stability, which can leave toxic residues and compromise cell viability. To address these challenges, a fully xeno-free and mechanically stable bioink is developed based on self-assembled peptides and cellulose nanofibers. The bioink combines 9-Fluorenylmethoxycarbonyl diphenylalanine (Fmoc-FF) and its ethylene glycol-conjugated derivative with a biodegradable fibrillar network of cellulose nanofibers, forming a non-cross-linked 3D scaffold. This formulation closely mimics the ECM, as confirmed by high-resolution microscopy, and supports over 95% cell viability, demonstrating exceptional biocompatibility. This work presents a novel xeno-free bioink with self-assembly and self-supporting properties, enabling reproducible 3D printing for advanced biomedical applications, including bone regeneration and personalized medicine.

Indexed as

Biocompatible MaterialsCelluloseInkNanofibersPeptidesPrinting, Three-DimensionalAnimalsCell SurvivalExtracellular MatrixHumansTissue EngineeringTissue ScaffoldsBiocompatible MaterialsCellulosePeptides3D printingbioinkcellulose nanofiberspeptidesself‐assemblytissue regenerationxeno‐free

Identifiers

PMID40908800
PMCPMC12817109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.